tert-Butyl 8-hydroxy-5-azaspiro[3.5]nonane-5-carboxylate, 95.0%, 500mg

4-Fluoro-3-(methylsulfanyl)benzoic acid, 95+%, 1g

2-Amino-N-(2-methoxyethyl)-4,5,6,7-tetrahydro-1-benzothiophene- 3-carboxamide, 95.0%, 2.5g

4-Cyano-3-ethoxyphenylboronic acid, 97%, 250mg

2-(8-Chloro-7-fluoronaphthalen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 100mg

(3R,5R)-1-[(tert-butoxy)carbonyl]-5-methylpyrrolidine-3-carboxylic acid, 95%, 1g

Bis((R)-4-methyl-4,5-dihydrooxazol-2-yl)methane, 97%, 250mg

Membrane de dialyse Spectra/Por® 1 à 4 Spectra/Por® 4 - MWCO 12 000 à 14 000, 32 mm, 30 m, 1 Pièce(s)

6-(3-(Trifluoromethyl)phenyl)picolinic acid, 95%, 500mg

2-Bromohexanoic acid, 98%, 25g

tert-Butyl (R)-2-bromo-4-methylpentanoate, 97%, 250mg

N-Methylsaccharin>98.0%(GC)25g

1-(1-(PIPERIDIN-4-YL)-1H-PYRAZOL-4-YL)ANTHRACENE-9,10-DIONE HYDROCHLORIDE, 95%, 50mg